1.Early application of bronchoalveolar lavage with electronic bronchoscopy in pediatric drowning cases:Single-center experience
Xiong ZHOU ; Jie HE ; Ying LIU ; Kang HUANG ; Yani PENG ; Desheng ZHU ; Zhenghui XIAO ; Xinping ZHANG
Chinese Pediatric Emergency Medicine 2025;32(1):50-55
Objective:To evaluate the efficacy of early bronchoalveolar lavage using electronic bronchoscopy in pediatric drowning cases.Methods:A retrospective analysis of clinical data from 81 pediatric drowning cases treated in the intensive care unit of Hunan Children's Hospital from January 2017 to September 2023 was conducted.Among these,43 cases underwent bronchoalveolar lavage with electronic bronchoscopy within 24 hours of drowning,constituting the treatment group,while 38 cases either did not receive treatment within 24 hours or underwent the procedure after 24 hours,forming the control group.We compared the two groups regarding pre-admission observations,admission observations,and disease progression or prognosis indicators to assess the clinical efficacy of early bronchoalveolar lavage with electronic bronchoscopy in pediatric drowning cases.Results:Compared to the control group,children in the treatment group exhibited a significant reduction in invasive ventilation time [(73.33±13.33) h vs.(94.82±15.77) h] and a significant decrease in pediatric intensive care unit stay [105.00 (94.00,121.00) h vs.123.5 (109.75,149.00) h],with both differences being statistically significant( P<0.05).No significant differences in white blood cell count and neutrophil percentage were observed between the treatment group and control group at admission and on the first day( P>0.05).However,by the third day,there was a significant improvement in white blood cell count in both groups,with statistical significance( P<0.05).There was a significant decrease in C-reactive protein and procalcitonin levels between the treatment group and control group on the 1st and 3rd days,with the differences being significant( P<0.05).Six hours after electronic bronchoalveolar lavage,the P/F ratio in the treatment group was lower than that in the control group (177.09±41.27 vs. 233.50±48.23),but it increased more significantly at 24 hours (286.00±34.32 vs.256.34±44.22),with a significant difference between two groups.The positive rate of lavage fluid culture in the treatment group was significantly higher than that in the control group,and the difference was statistically significant( P<0.05).There was no significant difference in the number of organ function damage between two groups( P>0.05).However,regarding prognosis,the treatment group showed significantly better outcomes than the control group( P<0.05). Conclusion:For pediatric patients with wilderness drowning,early electronic bronchoscopy with alveolar lavage may shorten the duration of invasive mechanical ventilation and pediatric intensive care unit stay,improving prognosis,and is worth promoting.
2.Effect of isoniazid and rifapentine anti-tuberculosis on the pharmacokinetics of efavirenz in people living with HIV
Zhangyufan HE ; Qiaoling RUAN ; Xinping YANG ; Linmei PU ; Lingyun SHAO ; Wenhong ZHANG ; Yungui ZHANG ; Qingluan YANG
Chinese Journal of Infection and Chemotherapy 2025;25(2):162-167
Objective This study aimed to evaluate the interaction between antiretroviral drug efavirenz and anti-tuberculosis 1H3P3(isoniazid plus rifapentine)in people living with HIV.Methods HIV-positive individuals on efavirenz-containing(600 mg)antiretroviral therapy(ART)received 1H3P3 regimen containing rifapentine(450 mg)plus isoniazid(400 mg)3 times a week for 1 month.Efavirenz concentrations were measured at weeks 0,2,4,8.Rifapentine concentration was determined at weeks 2 and 4.HIV RNA load was determined at weeks 0 and 8.Treatment target was efavirenz concentration>1 mg/L.The anti-TB prevention was considered acceptable if the target of efavirenz concentration was achieved in more than 80%of participants.The participants were followed up for 18 months to evaluate the efficacy of treatment.Results Thirty-one participants living with HIV were enrolled in the study.Two participants were excluded from PK analysis because his/her baseline efavirenz concentration<1 mg/L,suggesting poor treatment adherence.Evaluable PK data were available for 29 participants,including 23(79.3%)males.The median[interquartile range(IQR)]age of the participants was 43.0(32.5,53.5)years.The median(IQR)efavirenz plasma concentration was 2.33(1.96,2.34)mg/L at week 0,2.32(1.90,3.28)mg/L at week 2,2.07(1.83,3.09)mg/L at week 4,and 2.71(2.14,3.33)mg/L at week 8.Efavirenz concentration did not show significant difference between the 4 time points(P>0.05).Median(IQR)rifapentine concentration was 9.36(6.23,16.47)mg/L at week 2,and 9.36(6.41,15.56)mg/L at week 4.Rifapentine concentration did not show significant difference between week 2 and week 4(P>0.05).Efavirenz concentrations was>1 mg/L in all participants at weeks 2,4,and 8.Furthermore,efavirenz concentration was significantly higher in females and patients with body weight<60 kg compared with males and those with body weight ≥60 kg(P<0.05).None of the participants had symptoms or signs of active tuberculosis during 18-month follow-up.Conclusions Isoniazid plus rifapentine(1H3P3 regimen)did not have significant effect on the plasma concentrations of efavirenz.
3.Application of doxycycline in severe macrolide-resistant mycoplasma pneumoniae pneumonia in children
Desheng ZHU ; Jie HE ; Zhenghui XIAO ; Xiong ZHOU ; Jiaotian HUANG ; Xinping ZHANG
Chinese Pediatric Emergency Medicine 2025;32(2):122-127
Objective:To investigate the efficacy and safety of doxycycline in children with macrolide-resistant mycoplasma pneumoniae pneumonia(MRMPP).Methods:A retrospective analysis was conducted on the data from 92 children with severe MRMPP admitted to the Intensive Care Unit of Hunan Children's Hospital from January 2020 to November 2023.Depending on antibiotic treatment strategies for mycoplasma pneumoniae,patients were divided into three groups:Doxycycline group(those treated with doxycycline,12 cases);Azithromycin group(those treated with azithromycin,53 cases);and Switch group(those switched from azithromycin to doxycycline,27 cases).Clinical outcomes and adverse reactions were compared among the three groups.Results:Significant statistical differences were found among the three groups in terms of age( F=49.365, P<0.001)and weight( H=40.595, P<0.001),with the Doxycycline group presenting the highest average age and median weight,followed by the Switch group,and then the Azithromycin group.After antibiotic treatment,children in the Doxycycline group,when compared to the Switch group and the Azithromycin group,showed a shorter fever resolution time[3.0(2.0,3.8)days vs.5.0(4.0,5.0)days vs.6.0(5.0,7.0)days, H=25.243, P<0.001],a higher defervescence rate at 48 hours and 72 hours (41.7% vs.0 vs.0 at 48 hours,and 75.0% vs.0% vs.5.7% at 72 hours,both P<0.001],a shorter mechanical ventilation duration[83.0(70.0,93.0)hours vs.135.0(129.0,172.0)hours vs.152.0(139.0,164.5)hours, H=9.980, P=0.007],a shorter ICU stay[7.0(6.0,8.0)days vs.10.0(8.0,13.0)days vs.11.0(9.0,13.0)days, H=21.887, P<0.001],and a lower proportion of Methylprednisolone usage [8.3% vs.57.1% vs.54.7%, P=0.008].There was no significant statistical difference in extrapulmonary complications and co-pathogens(both P>0.05).Gastrointestinal reactions occurred in all children treated with doxycycline and azithromycin,with rates of 10.3%(4/39)and 13.8%(11/80),respectively,showing no statistical significance( P=0.771).Among the 67(72.8%)cases with available follow-up data,the incidence of bronchiolitis obliterans was 8.3%(1/12)in the Doxycycline group,13.6%(3/22)in the Switch group,and 15.2%(5/33)in the Azithromycin group,with no statistical significance( P>0.05).Among the 34 cases using doxycycline with follow-up data available,none had tooth discoloration or enamel hypoplasia related to the medication. Conclusion:Doxycycline in the treatment of severe MRMPP in children could rapidly improve clinical symptoms,shorten the course of the disease,reduce the likelihood of methylprednisolone use,and is relatively safe for short-term use.
4.Early application of bronchoalveolar lavage with electronic bronchoscopy in pediatric drowning cases:Single-center experience
Xiong ZHOU ; Jie HE ; Ying LIU ; Kang HUANG ; Yani PENG ; Desheng ZHU ; Zhenghui XIAO ; Xinping ZHANG
Chinese Pediatric Emergency Medicine 2025;32(1):50-55
Objective:To evaluate the efficacy of early bronchoalveolar lavage using electronic bronchoscopy in pediatric drowning cases.Methods:A retrospective analysis of clinical data from 81 pediatric drowning cases treated in the intensive care unit of Hunan Children's Hospital from January 2017 to September 2023 was conducted.Among these,43 cases underwent bronchoalveolar lavage with electronic bronchoscopy within 24 hours of drowning,constituting the treatment group,while 38 cases either did not receive treatment within 24 hours or underwent the procedure after 24 hours,forming the control group.We compared the two groups regarding pre-admission observations,admission observations,and disease progression or prognosis indicators to assess the clinical efficacy of early bronchoalveolar lavage with electronic bronchoscopy in pediatric drowning cases.Results:Compared to the control group,children in the treatment group exhibited a significant reduction in invasive ventilation time [(73.33±13.33) h vs.(94.82±15.77) h] and a significant decrease in pediatric intensive care unit stay [105.00 (94.00,121.00) h vs.123.5 (109.75,149.00) h],with both differences being statistically significant( P<0.05).No significant differences in white blood cell count and neutrophil percentage were observed between the treatment group and control group at admission and on the first day( P>0.05).However,by the third day,there was a significant improvement in white blood cell count in both groups,with statistical significance( P<0.05).There was a significant decrease in C-reactive protein and procalcitonin levels between the treatment group and control group on the 1st and 3rd days,with the differences being significant( P<0.05).Six hours after electronic bronchoalveolar lavage,the P/F ratio in the treatment group was lower than that in the control group (177.09±41.27 vs. 233.50±48.23),but it increased more significantly at 24 hours (286.00±34.32 vs.256.34±44.22),with a significant difference between two groups.The positive rate of lavage fluid culture in the treatment group was significantly higher than that in the control group,and the difference was statistically significant( P<0.05).There was no significant difference in the number of organ function damage between two groups( P>0.05).However,regarding prognosis,the treatment group showed significantly better outcomes than the control group( P<0.05). Conclusion:For pediatric patients with wilderness drowning,early electronic bronchoscopy with alveolar lavage may shorten the duration of invasive mechanical ventilation and pediatric intensive care unit stay,improving prognosis,and is worth promoting.
5.Effect of isoniazid and rifapentine anti-tuberculosis on the pharmacokinetics of efavirenz in people living with HIV
Zhangyufan HE ; Qiaoling RUAN ; Xinping YANG ; Linmei PU ; Lingyun SHAO ; Wenhong ZHANG ; Yungui ZHANG ; Qingluan YANG
Chinese Journal of Infection and Chemotherapy 2025;25(2):162-167
Objective This study aimed to evaluate the interaction between antiretroviral drug efavirenz and anti-tuberculosis 1H3P3(isoniazid plus rifapentine)in people living with HIV.Methods HIV-positive individuals on efavirenz-containing(600 mg)antiretroviral therapy(ART)received 1H3P3 regimen containing rifapentine(450 mg)plus isoniazid(400 mg)3 times a week for 1 month.Efavirenz concentrations were measured at weeks 0,2,4,8.Rifapentine concentration was determined at weeks 2 and 4.HIV RNA load was determined at weeks 0 and 8.Treatment target was efavirenz concentration>1 mg/L.The anti-TB prevention was considered acceptable if the target of efavirenz concentration was achieved in more than 80%of participants.The participants were followed up for 18 months to evaluate the efficacy of treatment.Results Thirty-one participants living with HIV were enrolled in the study.Two participants were excluded from PK analysis because his/her baseline efavirenz concentration<1 mg/L,suggesting poor treatment adherence.Evaluable PK data were available for 29 participants,including 23(79.3%)males.The median[interquartile range(IQR)]age of the participants was 43.0(32.5,53.5)years.The median(IQR)efavirenz plasma concentration was 2.33(1.96,2.34)mg/L at week 0,2.32(1.90,3.28)mg/L at week 2,2.07(1.83,3.09)mg/L at week 4,and 2.71(2.14,3.33)mg/L at week 8.Efavirenz concentration did not show significant difference between the 4 time points(P>0.05).Median(IQR)rifapentine concentration was 9.36(6.23,16.47)mg/L at week 2,and 9.36(6.41,15.56)mg/L at week 4.Rifapentine concentration did not show significant difference between week 2 and week 4(P>0.05).Efavirenz concentrations was>1 mg/L in all participants at weeks 2,4,and 8.Furthermore,efavirenz concentration was significantly higher in females and patients with body weight<60 kg compared with males and those with body weight ≥60 kg(P<0.05).None of the participants had symptoms or signs of active tuberculosis during 18-month follow-up.Conclusions Isoniazid plus rifapentine(1H3P3 regimen)did not have significant effect on the plasma concentrations of efavirenz.
6.Transcatheter edge-to-edge repair strategies for mitral commissural prolapse: a single-center experience
Xinping LIN ; Wangxing HU ; Qifeng ZHU ; Huajun LI ; Jie LIANG ; Huixiang YAN ; Lihan WANG ; Po HU ; Jubo JIANG ; Kaida REN ; Jiaqi FAN ; Yuxin HE ; Xianbao LIU ; Jian'an WANG
Chinese Journal of Cardiology 2025;53(4):356-362
Objective:To investigate the feasibility of transcatheter edge-to-edge repair (TEER) using a short-clip strategy for patients with moderate-to-severe or greater degenerative mitral regurgitation caused by commissural prolapse.Methods:This retrospective study included patients with severe mitral regurgitation secondary to commissural prolapse who underwent TEER at the Second Affiliated Hospital of Zhejiang University School of Medicine between September 2022 and July 2024. Preoperative clinical and imaging data, intraoperative details, procedural outcomes, and 1-month postoperative follow-up results were collected.Results:A total of 19 patients were enrolled, aged (74.1±6.1) years, including 12 males. Among them, 10 patients had external commissural prolapse, and 9 patients had internal commissural prolapse. Preoperatively, all patients exhibited severe mitral regurgitation (4+), with an effective regurgitant orifice area of (0.55±0.17) cm2, left atrial volume of (104.77±36.57) ml, left ventricular end-diastolic volume of (102.29±32.47) ml, left ventricular end-diastolic dimension of (5.34±0.59) mm, and prolapse width of (1.18±0.34) cm. All procedures utilized short clips (NTR or NTW clips) to target the prolapsed commissural region and were completed successfully without intraoperative complications. At 1-month follow-up, no mortality, stroke, single-leaflet device attachment, myocardial infarction, or unplanned mitral reintervention occurred. Mitral regurgitation severity improved to ≤2+ in all patients, with left atrial volume of (74.49±33.83) ml, left ventricular end-diastolic volume of (85.90±18.05) ml, and left ventricular end-diastolic dimension of (4.93±0.37) mm (all P<0.05). Conclusion:The short-clip strategy, focusing on precise clip placement at the commissural interface, is feasible and effective for TEER in patients with severe mitral regurgitation due to commissural prolapse.
7.Application of doxycycline in severe macrolide-resistant mycoplasma pneumoniae pneumonia in children
Desheng ZHU ; Jie HE ; Zhenghui XIAO ; Xiong ZHOU ; Jiaotian HUANG ; Xinping ZHANG
Chinese Pediatric Emergency Medicine 2025;32(2):122-127
Objective:To investigate the efficacy and safety of doxycycline in children with macrolide-resistant mycoplasma pneumoniae pneumonia(MRMPP).Methods:A retrospective analysis was conducted on the data from 92 children with severe MRMPP admitted to the Intensive Care Unit of Hunan Children's Hospital from January 2020 to November 2023.Depending on antibiotic treatment strategies for mycoplasma pneumoniae,patients were divided into three groups:Doxycycline group(those treated with doxycycline,12 cases);Azithromycin group(those treated with azithromycin,53 cases);and Switch group(those switched from azithromycin to doxycycline,27 cases).Clinical outcomes and adverse reactions were compared among the three groups.Results:Significant statistical differences were found among the three groups in terms of age( F=49.365, P<0.001)and weight( H=40.595, P<0.001),with the Doxycycline group presenting the highest average age and median weight,followed by the Switch group,and then the Azithromycin group.After antibiotic treatment,children in the Doxycycline group,when compared to the Switch group and the Azithromycin group,showed a shorter fever resolution time[3.0(2.0,3.8)days vs.5.0(4.0,5.0)days vs.6.0(5.0,7.0)days, H=25.243, P<0.001],a higher defervescence rate at 48 hours and 72 hours (41.7% vs.0 vs.0 at 48 hours,and 75.0% vs.0% vs.5.7% at 72 hours,both P<0.001],a shorter mechanical ventilation duration[83.0(70.0,93.0)hours vs.135.0(129.0,172.0)hours vs.152.0(139.0,164.5)hours, H=9.980, P=0.007],a shorter ICU stay[7.0(6.0,8.0)days vs.10.0(8.0,13.0)days vs.11.0(9.0,13.0)days, H=21.887, P<0.001],and a lower proportion of Methylprednisolone usage [8.3% vs.57.1% vs.54.7%, P=0.008].There was no significant statistical difference in extrapulmonary complications and co-pathogens(both P>0.05).Gastrointestinal reactions occurred in all children treated with doxycycline and azithromycin,with rates of 10.3%(4/39)and 13.8%(11/80),respectively,showing no statistical significance( P=0.771).Among the 67(72.8%)cases with available follow-up data,the incidence of bronchiolitis obliterans was 8.3%(1/12)in the Doxycycline group,13.6%(3/22)in the Switch group,and 15.2%(5/33)in the Azithromycin group,with no statistical significance( P>0.05).Among the 34 cases using doxycycline with follow-up data available,none had tooth discoloration or enamel hypoplasia related to the medication. Conclusion:Doxycycline in the treatment of severe MRMPP in children could rapidly improve clinical symptoms,shorten the course of the disease,reduce the likelihood of methylprednisolone use,and is relatively safe for short-term use.
8.Transcatheter edge-to-edge repair strategies for mitral commissural prolapse: a single-center experience
Xinping LIN ; Wangxing HU ; Qifeng ZHU ; Huajun LI ; Jie LIANG ; Huixiang YAN ; Lihan WANG ; Po HU ; Jubo JIANG ; Kaida REN ; Jiaqi FAN ; Yuxin HE ; Xianbao LIU ; Jian'an WANG
Chinese Journal of Cardiology 2025;53(4):356-362
Objective:To investigate the feasibility of transcatheter edge-to-edge repair (TEER) using a short-clip strategy for patients with moderate-to-severe or greater degenerative mitral regurgitation caused by commissural prolapse.Methods:This retrospective study included patients with severe mitral regurgitation secondary to commissural prolapse who underwent TEER at the Second Affiliated Hospital of Zhejiang University School of Medicine between September 2022 and July 2024. Preoperative clinical and imaging data, intraoperative details, procedural outcomes, and 1-month postoperative follow-up results were collected.Results:A total of 19 patients were enrolled, aged (74.1±6.1) years, including 12 males. Among them, 10 patients had external commissural prolapse, and 9 patients had internal commissural prolapse. Preoperatively, all patients exhibited severe mitral regurgitation (4+), with an effective regurgitant orifice area of (0.55±0.17) cm2, left atrial volume of (104.77±36.57) ml, left ventricular end-diastolic volume of (102.29±32.47) ml, left ventricular end-diastolic dimension of (5.34±0.59) mm, and prolapse width of (1.18±0.34) cm. All procedures utilized short clips (NTR or NTW clips) to target the prolapsed commissural region and were completed successfully without intraoperative complications. At 1-month follow-up, no mortality, stroke, single-leaflet device attachment, myocardial infarction, or unplanned mitral reintervention occurred. Mitral regurgitation severity improved to ≤2+ in all patients, with left atrial volume of (74.49±33.83) ml, left ventricular end-diastolic volume of (85.90±18.05) ml, and left ventricular end-diastolic dimension of (4.93±0.37) mm (all P<0.05). Conclusion:The short-clip strategy, focusing on precise clip placement at the commissural interface, is feasible and effective for TEER in patients with severe mitral regurgitation due to commissural prolapse.
9.Serum Metabolomics Analysis of Baicalein for Prevention and Treatment of Radiation-Induced Intestinal Damage in Mice Based on GC-MS
Yejin ZHU ; Xinping WANG ; Qianyi WANG ; Jun HE ; Xingde ZHANG ; Chao JIANG
Journal of Nanjing University of Traditional Chinese Medicine 2024;40(7):702-709
OBJECTIVE To investigate the changes in serum metabolites of mice with radiation-induced intestinal injury under the intervention of baicalein and the changing characteristics of endogenous biological small molecules during the process of baicalein's participation in the prevention and treatment of radiation-induced intestinal injury through the metabolomics method based on GC-MS technology,in order to explore the potential regulatory mechanism of baicalein.METHODS A mouse radioactive intestinal injury model was established and randomly divided into normal control group,model group,low-dose baicalein group and high-dose baica-lein group.Baicalein was administered by gavage.Gas chromatography-mass spectrometry(GC-MS)technology was used to analyze the serum samples of mice in each group,and differential metabolites were screened through partial least squares-discriminant analysis(PLS-DA).Potential metabolic pathways were analyzed with MetaboAnalyst.RESULTS The pathological sections of mouse intesti-nal tissue showed that the high-dose and low-dose baicalein groups had a certain protective effect on radiation-induced intestinal dam-age.Metabolomic analysis showed that there were significant differences in the metabolic profiles of the blank control group,model group,low-dose and high-dose baicalein administration groups.After intragastric administration of baicalein,the endogenous metabo-lites in mice with radiation intestinal injury tended to normalize.The study screened out a total of 11 potential metabolic markers and 5 related metabolic pathways,among which pathways related to glucose metabolism,glutathione pathway,and ammonia metabolism were particularly significant.CONCLUSION Baicalein has a certain preventive and therapeutic effect on radiation-induced intestinal in-jury;baicalein participates in glucose metabolism and glutathione metabolism,and improving the endogenous substance disorder caused by radiation is its potential mechanism of action.
10.Anterolateral mini-incision assisted reduction with InterTan intramedullary nail in treating elderly refractory femoral intertrochanteric fractures
Jianji LIANG ; Zhiyong HE ; Xinping YU
Chongqing Medicine 2024;53(13):2000-2004,2010
Objective To investigate the clinical effect of anterolateral mini-incision assisted reduction with InterTan intramedullary nail in the treatment of elderly refractory femoral intertrochanteric fractures to provide reference for clinical treatment.Methods Fifty-eight elderly patients with femoral intertrochanteric fractures admitted and treated in this hospital from August 2020 to April 2023 were selected as the study sub-jects and divided into the observation group and control group accroding to the operation program,29 cases in each group.The observation adopted the anterolateral mini-incision assisted reduction with InterTan intramed-ullary nail,in which there were 6 males and 23 females,the age averaged(86.14±4.98)years old.The control group adopted the closed reduction InterTan intramedullary nail therapy,in which there were 8 males and 21 females,the age averaged(86.33±5.09)years old.The intraoperative bleeding volume,hospitalization dura-tion,incidence rate of fracture related complications,operation time,postoperative fracture reduction quality,postoperative medial cortical support type and postoperative hip joint Harris score were compared between the two groups.Results The two groups obtained the followed up,the follow up time was 6-12 months,with an average(11.45±1.59)months.There were no statistically significant differences in the intraoperative bleed-ing volume,hospitalization duration,incidence rate of fracture related complications between two groups(P>0.05).The operation time in the observation group was(88.79±29.58)min,which in the control group was(70.66±24.47)min,and there was statistical difference between the two groups(P<0.05).The excellent and good rate of fracture reduction quality in the observation group was 100.00%,which in the control group was 75.86%,and the difference between the two groups had statistical significance(P<0.05).The propor-tion of positive and neutral medial cortical support in the observation group was 96.55%,which in control group was 72.41%,and the difference between the two groups was statistically significant(P<0.05).The hip Harris score in the observation group was(76.33±12.71)points,which in the control group was(68.39±13.17)points,and the difference between the two groups was statistically significant(P<0.05).Conclusion The eld-erly patients with refractory femoral intertrochanteric fracture are often combined with multiple underlying diseases,and the surgical risk is extremely high.Adopting anterolateral mini-incision assisted reduction with InterTan intramedullary nail fixation treatment could achieve the satisfactory reduction and fixation without increasing obvious trauma and the effect is reliable.

Result Analysis
Print
Save
E-mail